• 1. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 2. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 3. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Methoxybenzoic acids and derivatives

Methyl 5-iodo-2-methoxy-4-methylbenzoate (CAS No. 914225-32-4): A Versatile Intermediate in Modern Pharmaceutical Synthesis

Methyl 5-iodo-2-methoxy-4-methylbenzoate, identified by its CAS number 914225-32-4, is a significant compound in the realm of pharmaceutical chemistry. This benzoate derivative features a unique structural configuration that makes it a valuable intermediate in the synthesis of various bioactive molecules. The presence of both an iodine substituent and methoxy groups on the aromatic ring imparts distinct reactivity, enabling its use in multiple synthetic pathways.

The compound's molecular structure, characterized by a methyl group at the 4-position and methoxy at the 2-position, alongside the iodine atom at the 5-position, provides a rich platform for further functionalization. This makes Methyl 5-iodo-2-methoxy-4-methylbenzoate particularly useful in cross-coupling reactions, such as Suzuki-Miyaura and Stille couplings, which are pivotal in constructing complex organic molecules.

In recent years, there has been growing interest in utilizing such halogenated benzoates as building blocks for drug development. The iodine atom, in particular, serves as an excellent handle for palladium-catalyzed reactions, facilitating the introduction of diverse functional groups. This property has been leveraged in the synthesis of novel therapeutic agents targeting various diseases, including oncology and infectious disorders.

One of the most compelling applications of Methyl 5-iodo-2-methoxy-4-methylbenzoate is in the development of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways, and their dysregulation is often associated with cancer and inflammatory diseases. By employing this compound as a precursor, researchers have been able to design inhibitors that selectively target specific kinases, thereby enhancing therapeutic efficacy while minimizing side effects.

Moreover, the methoxy and methyl groups on the aromatic ring contribute to the compound's solubility and bioavailability, making it an attractive candidate for further pharmacological exploration. The benzoate moiety itself is known to enhance metabolic stability, a critical factor in drug design. These attributes collectively position Methyl 5-iodo-2-methoxy-4-methylbenzoate as a cornerstone in the synthesis of next-generation pharmaceuticals.

Recent studies have also highlighted its role in the development of antiviral agents. The structural features of this compound allow for interactions with viral proteases and polymerases, inhibiting their activity and thereby reducing viral replication. Such findings underscore its potential not only as a kinase inhibitor but also as a broad-spectrum antiviral agent.

The synthesis of Methyl 5-iodo-2-methoxy-4-methylbenzoate typically involves multi-step organic transformations starting from commercially available aromatic precursors. The process often includes halogenation, methylation, and esterification steps, each meticulously optimized to ensure high yield and purity. Advanced catalytic systems have been employed to enhance reaction efficiency and selectivity, reflecting the ongoing refinement of synthetic methodologies.

In conclusion, Methyl 5-iodo-2-methoxy-4-methylbenzoate (CAS No. 914225-32-4) stands out as a versatile intermediate with far-reaching applications in pharmaceutical research and development. Its unique structural features enable diverse functionalization strategies, making it indispensable in constructing complex bioactive molecules. As research continues to uncover new therapeutic targets and synthetic methodologies, this compound will undoubtedly remain at the forefront of medicinal chemistry innovation.

• 193882-67-6(Methyl 2-ethoxy-5-iodobenzoate)
• 148490-97-5(Methyl 4-iodo-2-methoxybenzoate)
• 1752-02-9(Benzoic acid, 6-iodo-2,3,4-trimethoxy-, methyl ester)
• 146335-26-4(Methyl 2-(benzyloxy)-5-iodobenzoate)
• 40757-09-3(Methyl 5-iodo-2-methoxybenzoate)
• 1269461-73-5(Methyl 5-iodo-2-(2-(methoxycarbonyl)-phenoxy)benzoate)
• 1241674-09-8(5-Iodo-2-methoxy-4-methylbenzoic acid)
• 1131587-53-5(Methyl 2-iodo-5-methoxy-[1,1'-biphenyl]-4-carboxylate)
• 850146-80-4(Methyl 2-hydroxy-5-iodo-4-methylbenzoate)
• 6082-99-1(Benzoic acid, 5-iodo-2-methoxy-3-methyl-, methyl ester)